Huang Tianyi, Saxena Aditi R, Isganaitis Elvira, James-Todd Tamarra
Division of Women's Health, Department of Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
Environ Health. 2014 Feb 5;13(1):6. doi: 10.1186/1476-069X-13-6.
Phthalates are ubiquitous endocrine disrupting chemicals associated with diabetes. Although women and minorities are more likely to be exposed to phthalates, no prior studies have examined phthalate exposure and markers of diabetes risk evaluating effect modification by gender and race/ethnicity.
We analyzed CDC data for 8 urinary phthalate metabolites from 3,083 non-diabetic, non-pregnant participants aged 12- < 80 years in the National Health and Nutrition Examination Survey (NHANES) 2001-2008. We used median regression to assess the associations between urinary phthalate metabolites and fasting blood glucose (FBG), fasting insulin and Homeostatic Model Assessment of insulin resistance (HOMA-IR), controlling for urinary creatinine as well as several sociodemographic and behavioral factors. Stratified analyses were conducted to compare the gender- and race/ethnicity-specific patterns for the associations.
Urinary levels of several phthalate metabolites, including MBzP, MnBP, MiBP, MCPP and ∑DEHP showed significant positive associations with FBG, fasting insulin and HOMA-IR. No clear difference was noted between men and women. Mexican-Americans and non-Hispanic blacks had stronger dose-response relationships for MnBP, MiBP, MCPP and ∑DEHP compared to non-Hispanic whites. For example, the highest quartile of MiBP relative to its lowest quartile showed a median FBG increase of 5.82 mg/dL (95% CI: 3.77, 7.87) in Mexican-Americans, 3.63 mg/dL (95% CI: 1.23, 6.03) in blacks and 1.79 mg/dL (95% CI: -0.29, 3.87) in whites.
The findings suggest that certain populations may be more vulnerable to phthalates with respect to disturbances in glucose homeostasis. Whether endocrine disrupting chemicals contribute to gender and racial/ethnic differences in diabetes risk will be an important area for further study.
邻苯二甲酸盐是普遍存在的内分泌干扰化学物质,与糖尿病有关。尽管女性和少数族裔更有可能接触邻苯二甲酸盐,但此前尚无研究探讨邻苯二甲酸盐暴露与糖尿病风险标志物之间的关系,并评估性别和种族/族裔对其影响的修正作用。
我们分析了美国国家健康与营养检查调查(NHANES)2001 - 2008年中3083名年龄在12至80岁之间的非糖尿病、非孕妇参与者的8种尿邻苯二甲酸酯代谢物的疾病预防控制中心(CDC)数据。我们使用中位数回归来评估尿邻苯二甲酸酯代谢物与空腹血糖(FBG)、空腹胰岛素和胰岛素抵抗稳态模型评估(HOMA - IR)之间的关联,并对尿肌酐以及一些社会人口统计学和行为因素进行了控制。进行分层分析以比较关联的性别和种族/族裔特异性模式。
几种邻苯二甲酸酯代谢物的尿水平,包括单丁基邻苯二甲酸酯(MBzP)、单甲基邻苯二甲酸酯(MnBP)、单异丁基邻苯二甲酸酯(MiBP)、单(2 - 乙基己基)邻苯二甲酸酯(MCPP)和总邻苯二甲酸二(2 - 乙基己基)酯(∑DEHP)与FBG、空腹胰岛素和HOMA - IR呈显著正相关。男性和女性之间未发现明显差异。与非西班牙裔白人相比,墨西哥裔美国人和非西班牙裔黑人在MnBP、MiBP、MCPP和∑DEHP方面具有更强的剂量反应关系。例如,MiBP最高四分位数相对于其最低四分位数,墨西哥裔美国人的FBG中位数增加5.82mg/dL(95%置信区间:3.77,7.87),黑人增加3.63mg/dL(95%置信区间:1.23,6.03),白人增加1.79mg/dL(95%置信区间: - 0.29,3.87)。
研究结果表明,某些人群在葡萄糖稳态紊乱方面可能对邻苯二甲酸盐更为敏感。内分泌干扰化学物质是否导致糖尿病风险的性别和种族/族裔差异将是进一步研究的重要领域。